Growth Metrics

Bristol Myers Squibb (BMYMP) Cash from Investing Activities (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Cash from Investing Activities for 17 consecutive years, with -$1.5 billion as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 643.88% to -$1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.1 billion through Dec 2025, up 80.65% year-over-year, with the annual reading at -$4.1 billion for FY2025, 80.65% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$1.5 billion at Bristol Myers Squibb, up from -$1.7 billion in the prior quarter.
  • The five-year high for Cash from Investing Activities was $1.2 billion in Q4 2022, with the low at -$19.6 billion in Q1 2024.
  • Average Cash from Investing Activities over 5 years is -$1.5 billion, with a median of -$369.5 million recorded in 2023.
  • The sharpest move saw Cash from Investing Activities soared 202.49% in 2022, then plummeted 9241.9% in 2024.
  • Over 5 years, Cash from Investing Activities stood at $401.0 million in 2021, then skyrocketed by 202.49% to $1.2 billion in 2022, then tumbled by 210.96% to -$1.3 billion in 2023, then soared by 85.44% to -$196.0 million in 2024, then crashed by 643.88% to -$1.5 billion in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$1.5 billion, -$1.7 billion, and -$473.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.